Pune, India -- (SBWIRE) -- 11/29/2019 -- The Infinium Global Research analyzes the  "Pompe Disease Treatment Market (Therapy Type - Enzyme Replacement Therapy, and Substrate Reduction Therapy; Molecule Type - Biologics, and Small Molecules; Route of Administration - Oral, and Parenteral; Dosage Forms - Solid, and Liquid): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025". The global Pompe disease treatment market is projected to grow at a CAGR of 9.0% over the forecast period of 2019-2025.

Pompe disease is a progressive disease that gets worse over time. This disease causes progressive muscle weakness and often leads to breathing problems. Pomp disease is also considered as a metabolic muscle disease. It is similar to other neuromuscular disorders such as muscular dystrophies. The symptoms of Pompe disease are insufficient or missing amounts of an enzyme called acid alpha-glucosidase (GAA). This enzyme is needed to break down a complex sugar molecule into glucose

For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/13396

Audentes Therapeutics Intended AT845 to Provide Long-Term Production of an Enzyme

In January 2019, Audentes Therapeutics Planned to File Investigational New Drug Application for Potential Pompe disease gene therapy AT845.AT845 is intended to provide long-term production of an enzyme called acid alpha-glucosidase (GAA) that required to break down glycogen into glucose. Pompe disease is caused by mutations in the GAA gene, which impair the activity or production of the enzyme.

Emerging Immunotherapeutic Approaches Generate Opportunities For Pompe Disease Treatment Market

Growing prevalence of pompe disease among population, Enzyme replacement therapies and growing developments in gene therapy are driving the growth of the Pompe disease treatment market. However, expensive therapy treatments are hindering the growth of the market. Moreover, emerging immunotherapeutic approaches for Pompe disease provide growth opportunities for Pompe disease treatment market

Enquire here Get Customization & Check Discount for Report @ https://www.infiniumglobalresearch.com/reports/request-discount/13396

Enzyme Replacement Therapy Segment leads the Pompe Disease Treatment Market in 2019

The pompe disease treatment market is segmented into therapy type, molecule type, and route of administration and dosage forms. On the basis of therapy type, it is segmented into enzyme replacement therapy and substrate reduction therapy. On the basis of molecule type, it is consists of biologics and small molecules. On the basis of the route of administration, it involves oral and parenteral. The Pompe disease treatment market on basis of dosage forms bifurcated into solid and liquid.

North America Holds the Largest Share in the Global Pompe Disease Treatment Market

The pompe disease treatment market based on region segmented into North America, Europe, the Asia Pacific and the RoW. North America is the largest region for the global Pompe disease treatment market. Asia Pacific is expected to grow with healthy CAGR owing to healthcare facilities and increasing awareness among patients regarding rare disorders

Pompe Disease Market: Competitive Landscape

The key players in the global pompe disease treatment market are BioMarin Pharmaceutical, Amicus Therapeutics, Genzyme company, Oxyrane, Audentes Therapeutics, Sangamo BioSciences, EpiVax, and Valerion Therapeutics.

Browse Complete Global Report and Detailed TOC: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-pompe-disease-treatment-market

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the pompe disease treatment.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.